List of Tables
Table 1. Global Meningococcal Disease Vaccine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Meningococcal Disease Vaccine Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Meningococcal Disease Vaccine Market Competitive Situation by Manufacturers in 2024
Table 4. Global Meningococcal Disease Vaccine Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Meningococcal Disease Vaccine Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Meningococcal Disease Vaccine Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Meningococcal Disease Vaccine Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Meningococcal Disease Vaccine Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Meningococcal Disease Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Meningococcal Disease Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Meningococcal Disease Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of Meningococcal Disease Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Meningococcal Disease Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Meningococcal Disease Vaccine as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Meningococcal Disease Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Meningococcal Disease Vaccine Sales by Region (2020-2025) & (K Units)
Table 18. Global Meningococcal Disease Vaccine Sales Market Share by Region (2020-2025)
Table 19. Global Meningococcal Disease Vaccine Sales by Region (2026-2031) & (K Units)
Table 20. Global Meningococcal Disease Vaccine Sales Market Share by Region (2026-2031)
Table 21. Global Meningococcal Disease Vaccine Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Meningococcal Disease Vaccine Revenue Market Share by Region (2020-2025)
Table 23. Global Meningococcal Disease Vaccine Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Meningococcal Disease Vaccine Revenue Market Share by Region (2026-2031)
Table 25. North America Meningococcal Disease Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Meningococcal Disease Vaccine Sales by Country (2020-2025) & (K Units)
Table 27. North America Meningococcal Disease Vaccine Sales by Country (2026-2031) & (K Units)
Table 28. North America Meningococcal Disease Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Meningococcal Disease Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Meningococcal Disease Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Meningococcal Disease Vaccine Sales by Country (2020-2025) & (K Units)
Table 32. Europe Meningococcal Disease Vaccine Sales by Country (2026-2031) & (K Units)
Table 33. Europe Meningococcal Disease Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Meningococcal Disease Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Meningococcal Disease Vaccine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Meningococcal Disease Vaccine Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Meningococcal Disease Vaccine Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Meningococcal Disease Vaccine Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Meningococcal Disease Vaccine Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Meningococcal Disease Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Meningococcal Disease Vaccine Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Meningococcal Disease Vaccine Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Meningococcal Disease Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Meningococcal Disease Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Meningococcal Disease Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Meningococcal Disease Vaccine Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Meningococcal Disease Vaccine Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Meningococcal Disease Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Meningococcal Disease Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Meningococcal Disease Vaccine Sales (K Units) by Type (2020-2025)
Table 51. Global Meningococcal Disease Vaccine Sales (K Units) by Type (2026-2031)
Table 52. Global Meningococcal Disease Vaccine Sales Market Share by Type (2020-2025)
Table 53. Global Meningococcal Disease Vaccine Sales Market Share by Type (2026-2031)
Table 54. Global Meningococcal Disease Vaccine Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Meningococcal Disease Vaccine Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Meningococcal Disease Vaccine Revenue Market Share by Type (2020-2025)
Table 57. Global Meningococcal Disease Vaccine Revenue Market Share by Type (2026-2031)
Table 58. Global Meningococcal Disease Vaccine Price (US$/Unit) by Type (2020-2025)
Table 59. Global Meningococcal Disease Vaccine Price (US$/Unit) by Type (2026-2031)
Table 60. Global Meningococcal Disease Vaccine Sales (K Units) by Application (2020-2025)
Table 61. Global Meningococcal Disease Vaccine Sales (K Units) by Application (2026-2031)
Table 62. Global Meningococcal Disease Vaccine Sales Market Share by Application (2020-2025)
Table 63. Global Meningococcal Disease Vaccine Sales Market Share by Application (2026-2031)
Table 64. Global Meningococcal Disease Vaccine Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Meningococcal Disease Vaccine Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Meningococcal Disease Vaccine Revenue Market Share by Application (2020-2025)
Table 67. Global Meningococcal Disease Vaccine Revenue Market Share by Application (2026-2031)
Table 68. Global Meningococcal Disease Vaccine Price (US$/Unit) by Application (2020-2025)
Table 69. Global Meningococcal Disease Vaccine Price (US$/Unit) by Application (2026-2031)
Table 70. AstraZeneca Company Information
Table 71. AstraZeneca Description and Business Overview
Table 72. AstraZeneca Meningococcal Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. AstraZeneca Meningococcal Disease Vaccine Product
Table 74. AstraZeneca Recent Developments/Updates
Table 75. Johnson & Johnson Company Information
Table 76. Johnson & Johnson Description and Business Overview
Table 77. Johnson & Johnson Meningococcal Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Johnson & Johnson Meningococcal Disease Vaccine Product
Table 79. Johnson & Johnson Recent Developments/Updates
Table 80. Mylan N.V Company Information
Table 81. Mylan N.V Description and Business Overview
Table 82. Mylan N.V Meningococcal Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Mylan N.V Meningococcal Disease Vaccine Product
Table 84. Mylan N.V Recent Developments/Updates
Table 85. Teva Pharmaceutical Industries Ltd Company Information
Table 86. Teva Pharmaceutical Industries Ltd Description and Business Overview
Table 87. Teva Pharmaceutical Industries Ltd Meningococcal Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Teva Pharmaceutical Industries Ltd Meningococcal Disease Vaccine Product
Table 89. Teva Pharmaceutical Industries Ltd Recent Developments/Updates
Table 90. Pfizer Inc Company Information
Table 91. Pfizer Inc Description and Business Overview
Table 92. Pfizer Inc Meningococcal Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Pfizer Inc Meningococcal Disease Vaccine Product
Table 94. Pfizer Inc Recent Developments/Updates
Table 95. GlaxoSmithKline plc Company Information
Table 96. GlaxoSmithKline plc Description and Business Overview
Table 97. GlaxoSmithKline plc Meningococcal Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. GlaxoSmithKline plc Meningococcal Disease Vaccine Product
Table 99. GlaxoSmithKline plc Recent Developments/Updates
Table 100. Novartis AG Company Information
Table 101. Novartis AG Description and Business Overview
Table 102. Novartis AG Meningococcal Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Novartis AG Meningococcal Disease Vaccine Product
Table 104. Novartis AG Recent Developments/Updates
Table 105. Sanofi Company Information
Table 106. Sanofi Description and Business Overview
Table 107. Sanofi Meningococcal Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Sanofi Meningococcal Disease Vaccine Product
Table 109. Sanofi Recent Developments/Updates
Table 110. Merck & Co., Inc. Company Information
Table 111. Merck & Co., Inc. Description and Business Overview
Table 112. Merck & Co., Inc. Meningococcal Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Merck & Co., Inc. Meningococcal Disease Vaccine Product
Table 114. Merck & Co., Inc. Recent Developments/Updates
Table 115. F. Hoffmann-La Roche Ltd Company Information
Table 116. F. Hoffmann-La Roche Ltd Description and Business Overview
Table 117. F. Hoffmann-La Roche Ltd Meningococcal Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. F. Hoffmann-La Roche Ltd Meningococcal Disease Vaccine Product
Table 119. F. Hoffmann-La Roche Ltd Recent Developments/Updates
Table 120. Baxter Company Information
Table 121. Baxter Description and Business Overview
Table 122. Baxter Meningococcal Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Baxter Meningococcal Disease Vaccine Product
Table 124. Baxter Recent Developments/Updates
Table 125. BIO-MED Company Information
Table 126. BIO-MED Description and Business Overview
Table 127. BIO-MED Meningococcal Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. BIO-MED Meningococcal Disease Vaccine Product
Table 129. BIO-MED Recent Developments/Updates
Table 130. Bio-Manguinhos Company Information
Table 131. Bio-Manguinhos Description and Business Overview
Table 132. Bio-Manguinhos Meningococcal Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Bio-Manguinhos Meningococcal Disease Vaccine Product
Table 134. Bio-Manguinhos Recent Developments/Updates
Table 135. Walvax Biotechnology Co., Ltd Company Information
Table 136. Walvax Biotechnology Co., Ltd Description and Business Overview
Table 137. Walvax Biotechnology Co., Ltd Meningococcal Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. Walvax Biotechnology Co., Ltd Meningococcal Disease Vaccine Product
Table 139. Walvax Biotechnology Co., Ltd Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Meningococcal Disease Vaccine Distributors List
Table 143. Meningococcal Disease Vaccine Customers List
Table 144. Meningococcal Disease Vaccine Market Trends
Table 145. Meningococcal Disease Vaccine Market Drivers
Table 146. Meningococcal Disease Vaccine Market Challenges
Table 147. Meningococcal Disease Vaccine Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
Table 151. Authors List of This Report
List of Figures
Figure 1. Product Picture of Meningococcal Disease Vaccine
Figure 2. Global Meningococcal Disease Vaccine Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Meningococcal Disease Vaccine Market Share by Type: 2024 & 2031
Figure 4. Polysaccharide Product Picture
Figure 5. Conjugate Product Picture
Figure 6. Combination Product Picture
Figure 7. Global Meningococcal Disease Vaccine Market Value by Application (2020-2031) & (US$ Million)
Figure 8. Global Meningococcal Disease Vaccine Market Share by Application: 2024 & 2031
Figure 9. Infant
Figure 10. Child
Figure 11. Aldult
Figure 12. Global Meningococcal Disease Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Meningococcal Disease Vaccine Market Size (2020-2031) & (US$ Million)
Figure 14. Global Meningococcal Disease Vaccine Sales (2020-2031) & (K Units)
Figure 15. Global Meningococcal Disease Vaccine Average Price (US$/Unit) & (2020-2031)
Figure 16. Meningococcal Disease Vaccine Report Years Considered
Figure 17. Meningococcal Disease Vaccine Sales Share by Manufacturers in 2024
Figure 18. Global Meningococcal Disease Vaccine Revenue Share by Manufacturers in 2024
Figure 19. Global 5 and 10 Largest Meningococcal Disease Vaccine Players: Market Share by Revenue in Meningococcal Disease Vaccine in 2024
Figure 20. Meningococcal Disease Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 21. Global Meningococcal Disease Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 22. North America Meningococcal Disease Vaccine Sales Market Share by Country (2020-2031)
Figure 23. North America Meningococcal Disease Vaccine Revenue Market Share by Country (2020-2031)
Figure 24. United States Meningococcal Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Canada Meningococcal Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Europe Meningococcal Disease Vaccine Sales Market Share by Country (2020-2031)
Figure 27. Europe Meningococcal Disease Vaccine Revenue Market Share by Country (2020-2031)
Figure 28. Germany Meningococcal Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. France Meningococcal Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. U.K. Meningococcal Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Italy Meningococcal Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Russia Meningococcal Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Asia Pacific Meningococcal Disease Vaccine Sales Market Share by Region (2020-2031)
Figure 34. Asia Pacific Meningococcal Disease Vaccine Revenue Market Share by Region (2020-2031)
Figure 35. China Meningococcal Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Japan Meningococcal Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. South Korea Meningococcal Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. India Meningococcal Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Australia Meningococcal Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. China Taiwan Meningococcal Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Southeast Asia Meningococcal Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Latin America Meningococcal Disease Vaccine Sales Market Share by Country (2020-2031)
Figure 43. Latin America Meningococcal Disease Vaccine Revenue Market Share by Country (2020-2031)
Figure 44. Mexico Meningococcal Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Brazil Meningococcal Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Argentina Meningococcal Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Middle East and Africa Meningococcal Disease Vaccine Sales Market Share by Country (2020-2031)
Figure 48. Middle East and Africa Meningococcal Disease Vaccine Revenue Market Share by Country (2020-2031)
Figure 49. Turkey Meningococcal Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Saudi Arabia Meningococcal Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. UAE Meningococcal Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Global Sales Market Share of Meningococcal Disease Vaccine by Type (2020-2031)
Figure 53. Global Revenue Market Share of Meningococcal Disease Vaccine by Type (2020-2031)
Figure 54. Global Meningococcal Disease Vaccine Price (US$/Unit) by Type (2020-2031)
Figure 55. Global Sales Market Share of Meningococcal Disease Vaccine by Application (2020-2031)
Figure 56. Global Revenue Market Share of Meningococcal Disease Vaccine by Application (2020-2031)
Figure 57. Global Meningococcal Disease Vaccine Price (US$/Unit) by Application (2020-2031)
Figure 58. Meningococcal Disease Vaccine Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
